JOINN Laboratories (China) Co., Ltd. Class H (HK:6127) has released an update.
JOINN Laboratories (China) Co., Ltd. has announced the signing of crucial framework agreements for leasing and service provisions, expanding its business operations in biologics and AI services. The company has entered into agreements with connected entities, which will involve leasing certain properties in Beijing and providing BioAI services through 2024 and 2025. These transactions are in compliance with the Listing Rules, requiring reporting and annual review, but not needing independent shareholder approval.
For further insights into HK:6127 stock, check out TipRanks’ Stock Analysis page.
